The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...
Amazon S3 on MSN
How cloning could transform human life and health
Advances in cloning and stem cell technology may soon enable custom-grown organs and longer lifespans. Secret Service finds ...
Oct 6 (Reuters) - AstraZeneca (AZN.L), opens new tab has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
In an exciting scientific first, researchers at the Allen Institute successfully designed a new gene therapy that reversed symptoms related to SYNGAP1-related disorders (SRD) in mice. These are a ...
The company is gene editing crops to make our food supply more resilient to climate change. Climate change will make it increasingly difficult to grow crops across many parts of the world. Pairwise is ...
For decades, synthetic biologists have been developing gene circuits that can be transferred into cells for applications such as reprogramming a stem cell into a neuron or generating a protein that ...
A red quarter of a circle with the words 'The Quarter Mark' beside it. A year-long series looking back on the most significant moments of the past 25 years, how they changed our world, and how they ...
In a video shared on the social media platform X on Thursday, the investor shared his thoughts on the probe into Tesla. "I don't think that they're [NHTSA] going after Tesla per se," the investor said ...
GRAND HAVEN, MI -- The remains of a West Michigan native killed in the Pacific Theater during World War II have been identified using DNA and other technology. Staff with the Defense POW/MIA ...
Gene Munster, Deepwater Asset Management managing partner, joins 'The Exchange' to discuss why equity markets aren't in a bubble, the OpenAI-Broadcom deal and much more. Donald Trump says Republican ...
Oct 6 (Reuters) - Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca (AZN.L), opens new tab a license to develop therapies the U.S.-based biotech discover using its AI-driven gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback